Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer

NCT01656460 is registered in ClinicalTrials.gov with Dr Thomas DiPetrillo as lead sponsor.

NCT NCT01656460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01656460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stereotactic Body Radiation for Consolidation After Standard Chemoradiation for Stage 3 Lung Cancer
Lead sponsor
Dr Thomas DiPetrillo
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2012
Completion date
May 16, 2017
Enrollment
12 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer